ACM
ACIU icon

Aquilo Capital Management’s AC Immune ACIU Stock Holding History

Aquilo Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-463,575
Closed -$2.26M – 18
2020
Q3 		$2.26M Buy
+463,575
New +$3.33M 0.24% 15

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Aquilo Capital Management's ACIU Position: Q4 2020 in Review

Aquilo Capital Management sold out of AC Immune (ACIU) in Q4 2020, closing a stake of 463,575 shares — an estimated $2.26M sold.

Aquilo Capital Management first reported a position in ACIU in Q3 2020 and held it in 1 quarter. The position peaked at $2.26M in Q3 2020. 47 funds tracked by Wall St. Rank hold ACIU as of Q4 2020.

  • Aquilo Capital Management reported no remaining AC Immune position as of Q4 2020 after selling out during the quarter.
  • Aquilo Capital Management sold 463,575 AC Immune shares in Q4 2020, an estimated $2.26M.
  • Aquilo Capital Management first reported a position in AC Immune in Q3 2020 and held it in 1 quarter.
  • Aquilo Capital Management's AC Immune position peaked at $2.26M in Q3 2020.
  • 47 funds tracked by Wall St. Rank held AC Immune as of Q4 2020.

Based on Aquilo Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.